The observation that melanoma cells do not tolerate long-lasting, high levels of such Calpain-3 variant was a starting and useful indication about the detrimental effect of this protease to melanoma cells, and prompted us to perform experiments in transiently over-expressing cells. This evidence concerns the gene CAPN3 and melanoma.